446 related articles for article (PubMed ID: 19617306)
1. Stability of irinotecan-loaded drug eluting beads (DC Bead) used for transarterial chemoembolization.
Kaiser J; Thiesen J; Krämer I
J Oncol Pharm Pract; 2010 Mar; 16(1):53-61. PubMed ID: 19617306
[TBL] [Abstract][Full Text] [Related]
2. Loading, release and stability of epirubicin-loaded drug-eluting beads.
Spindeldreier KC; Thiesen J; Krämer I
J Oncol Pharm Pract; 2016 Aug; 22(4):591-8. PubMed ID: 26160072
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin-loaded drug-eluting beads (DC Bead®) for use in transarterial chemoembolization: a stability assessment.
Hecq JD; Lewis AL; Vanbeckbergen D; Athanosopoulos A; Galanti L; Jamart J; Czuczman P; Chung T
J Oncol Pharm Pract; 2013 Mar; 19(1):65-74. PubMed ID: 22801955
[TBL] [Abstract][Full Text] [Related]
4. Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media.
Sarakbi I; Krämer I
J Oncol Pharm Pract; 2016 Dec; 22(6):749-756. PubMed ID: 26428284
[TBL] [Abstract][Full Text] [Related]
5. Compatibility of irinotecan-loaded DC Bead with different volumes and types of non-ionic contrast media.
Sarakbi I; Thiesen J; Krämer I
Eur J Hosp Pharm; 2016 Jan; 23(1):38-43. PubMed ID: 31156812
[TBL] [Abstract][Full Text] [Related]
6. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization.
Lewis AL; Gonzalez MV; Lloyd AW; Hall B; Tang Y; Willis SL; Leppard SW; Wolfenden LC; Palmer RR; Stratford PW
J Vasc Interv Radiol; 2006 Feb; 17(2 Pt 1):335-42. PubMed ID: 16517780
[TBL] [Abstract][Full Text] [Related]
7. An in-vitro evaluation of three types of drug-eluting microspheres loaded with irinotecan.
Pereira PL; Plotkin S; Yu R; Sutter A; Wu Y; Sommer CM; Cruise GM
Anticancer Drugs; 2016 Oct; 27(9):873-8. PubMed ID: 27416270
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC bead and hepasphere loaded with doxorubicin and irinotecan.
Jordan O; Denys A; De Baere T; Boulens N; Doelker E
J Vasc Interv Radiol; 2010 Jul; 21(7):1084-90. PubMed ID: 20610183
[TBL] [Abstract][Full Text] [Related]
9. Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties.
Taylor RR; Tang Y; Gonzalez MV; Stratford PW; Lewis AL
Eur J Pharm Sci; 2007 Jan; 30(1):7-14. PubMed ID: 17030118
[TBL] [Abstract][Full Text] [Related]
10. Loading profile of topotecan into polyvinyl alcohol microspheres (DC Bead™) over a 7-day period.
Kaiser J; Krämer I
J Oncol Pharm Pract; 2012 Jun; 18(2):222-8. PubMed ID: 22075006
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy compared between irinotecan-loaded microspheres HepaSphere and DC bead in a model of VX2 liver metastases in the rabbit.
Namur J; Pascale F; Maeda N; Sterba M; Ghegediban SH; Verret V; Paci A; Seck A; Osuga K; Wassef M; Reb P; Laurent A
J Vasc Interv Radiol; 2015 Jul; 26(7):1067-1075.e3. PubMed ID: 25952641
[TBL] [Abstract][Full Text] [Related]
12. Preservation of the active lactone form of irinotecan using drug eluting beads for the treatment of colorectal cancer metastases.
Tang Y; Czuczman PR; Chung ST; Lewis AL
J Control Release; 2008 Apr; 127(1):70-8. PubMed ID: 18237814
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and antitumor efficacy of chemoembolization using 40 µm irinotecan-loaded microspheres in a rabbit liver tumor model.
Tanaka T; Nishiofuku H; Hukuoka Y; Sato T; Masada T; Takano M; Gilbert CW; Obayashi C; Kichikawa K
J Vasc Interv Radiol; 2014 Jul; 25(7):1037-1044.e2. PubMed ID: 24861663
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of ion exchange processes in drug-eluting embolization beads by use of an improved flow-through elution method.
Swaine T; Tang Y; Garcia P; John J; Waters LJ; Lewis AL
Eur J Pharm Sci; 2016 Oct; 93():351-9. PubMed ID: 27523788
[TBL] [Abstract][Full Text] [Related]
15. Comparison of DC Bead-irinotecan and DC Bead-topotecan drug eluting beads for use in locoregional drug delivery to treat pancreatic cancer.
Forster RE; Small SA; Tang Y; Heaysman CL; Lloyd AW; Macfarlane W; Phillips GJ; Antonijevic MD; Lewis AL
J Mater Sci Mater Med; 2010 Sep; 21(9):2683-90. PubMed ID: 20563626
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the plasmatic and parenchymal elution kinetics of two different irinotecan-loaded drug-eluting embolics in a pig model.
Gnutzmann DM; Mechel J; Schmitz A; Köhler K; Krone D; Bellemann N; Gockner TL; Mokry T; Kortes N; Sommer CM; Kauczor HU; Radeleff BA; Stampfl U
J Vasc Interv Radiol; 2015 May; 26(5):746-54. PubMed ID: 25704223
[TBL] [Abstract][Full Text] [Related]
17. An In Vitro Evaluation of Four Types of Drug-Eluting Microspheres Loaded with Doxorubicin.
de Baere T; Plotkin S; Yu R; Sutter A; Wu Y; Cruise GM
J Vasc Interv Radiol; 2016 Sep; 27(9):1425-1431. PubMed ID: 27402527
[TBL] [Abstract][Full Text] [Related]
18. An In Vitro Evaluation of Four Types of Drug-Eluting Embolics Loaded with Idarubicin.
Guiu B; Hincapie G; Thompson L; Wu Y; Boulin M; Cassinotto C; Cruise GM
J Vasc Interv Radiol; 2019 Aug; 30(8):1303-1309. PubMed ID: 31155500
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a novel intrinsically radiopaque Drug-eluting Bead for image-guided therapy: DC Bead LUMI™.
Ashrafi K; Tang Y; Britton H; Domenge O; Blino D; Bushby AJ; Shuturminska K; den Hartog M; Radaelli A; Negussie AH; Mikhail AS; Woods DL; Krishnasamy V; Levy EB; Wood BJ; Willis SL; Dreher MR; Lewis AL
J Control Release; 2017 Mar; 250():36-47. PubMed ID: 28188808
[TBL] [Abstract][Full Text] [Related]
20. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
Psathas PA; Kuzmission A; Ikeda K; Yasuo S
Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
